| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.6M | -71.2% |
| R&D Expense | $224.2M | +74.9% |
| SG&A Expense | $76.1M | +44.6% |
| Operating Income | -$289.7M | -101.4% |
| Pre-tax Income | -$274.9M | -91.2% |
| Income Tax | $1.4M | — |
| Net Income | -$276.3M | -92.2% |
| EPS (Basic) | -$8.74 | -76.9% |
| EPS (Diluted) | -$8.74 | -76.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $248.3M | +20.0% |
| Accounts Receivable | $57K | -96.7% |
| Current Assets | $1.15B | +123.2% |
| Total Assets | $1.16B | +120.5% |
| Current Liabilities | $33.9M | +67.9% |
| Total Liabilities | $37.1M | +44.7% |
| Stockholders' Equity | $1.13B | +124.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$228.0M | -126.0% |
| Capital Expenditures | $915K | -70.2% |
| Investing Cash Flow | -$586.4M | -2484.6% |
| Financing Cash Flow | $855.8M | +208.3% |
| Free Cash Flow | -$228.9M | -120.2% |